Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Medical College of Wisconsin
Medical College of Wisconsin
Sellas Life Sciences Group
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
Mayo Clinic
University of Maryland, Baltimore
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Montefiore Medical Center
AIDS Malignancy Consortium
Dartmouth-Hitchcock Medical Center
St. Jude Children's Research Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Alliance for Clinical Trials in Oncology
Beth Israel Deaconess Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sanofi
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
University of Alabama at Birmingham
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Emory University
Northwestern University
Auxilio Mutuo Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Scripps Health